Schwab stock heads into Fed week after Friday slide — what could move SCHW next

Schwab stock heads into Fed week after Friday slide — what could move SCHW next

New York, January 25, 2026, 15:50 EST — The market has closed.

  • Shares of Schwab fell 1.8% on Friday, finishing the day at $102.18.
  • Investors are bracing for the Fed’s Jan. 28 decision and major earnings reports on Monday.
  • Following Schwab’s quarterly update earlier this week, analysts have been adjusting their price targets.

Shares of The Charles Schwab Corp slipped 1.8% to close at $102.18 on Friday, wrapping up a turbulent week for U.S. investors who are now eyeing new catalysts on the horizon.

This hits Schwab hard since its earnings closely track shifts in rates and risk appetite. A big chunk of its revenue comes from interest on client cash, while market swings often trigger sharp rises or drops in trading activity.

The Federal Reserve is set to announce its decision on Wednesday, kicking off a packed week of earnings reports from major players like Apple, Microsoft, Meta Platforms, and Tesla. Yung‑Yu Ma, chief investment strategist at PNC Financial Services Group, described recent market moves as “a short but steep roller-coaster ride.” (Reuters)

On Friday, the Dow dropped 0.58%, the S&P 500 held steady, and the Nasdaq gained 0.28%. Intel’s weak guidance weighed on the market, while ongoing geopolitical tensions added to the uncertainty. “We feel pretty good about where we are today,” said Jason Blackwell, chief investment strategist at Focus Partners Wealth. (Reuters)

Analyst moves continued, with TD Cowen lifting its price target on Schwab from $135 to $138 while maintaining a buy rating, a report on Yahoo Finance showed. (Yahoo Finance)

On Jan. 21, Schwab announced that its fourth-quarter net revenue jumped 19% to $6.34 billion. Net income also climbed, reaching $2.46 billion, supported by a rise in interest income and stronger trading revenue amid a volatile environment. Net interest revenue—the difference between what it earns on assets and what it pays on liabilities—increased more than 25% to $3.17 billion, Reuters reported. (Reuters)

Schwab reported an 18% jump in total client assets year-over-year, hitting a new high of $11.90 trillion in its latest quarterly results. CEO Rick Wurster highlighted that 2025 “delivered growth on all fronts.” The firm also confirmed it still expects to complete its deal to acquire private-shares platform Forge Global in the first half of 2026. (Charles Schwab Press Room)

Over the weekend, peers showed mixed moves. Interactive Brokers edged up 0.5% on Friday, Robinhood Markets gained roughly 0.7%, but Schwab slipped lower.

The path isn’t smooth. Should the Fed push back more aggressively against rate cuts, or if new tariff news rattles confidence, Schwab could take a hit on both its market-sensitive fee revenue and the interest margin it earns on client cash.

As U.S. markets reopen Monday, Schwab investors will focus on Treasury yields and any changes to rate expectations ahead of the Fed’s Jan. 28 decision. They’ll also keep an eye on whether market volatility fuels retail trading or dampens it.

Stock Market Today

  • Eli Lilly Shares Dip After FDA Delays Approval of Orforglipron
    January 25, 2026, 4:20 PM EST. Eli Lilly (LLY) faced a nearly 4% share drop after the U.S. FDA extended the review period for orforglipron, an oral GLP-1 weight loss drug, delaying approval from February to April 10. This gives competitor Novo Nordisk more time to expand its oral GLP-1 drug market presence. Oral formulations target patients reluctant to use injections, broadening market reach. Despite the setback, Eli Lilly's Zepbound continues strong sales, even surpassing Novo Nordisk's Wegovy in some sales metrics, reflecting the importance of drug efficacy and safety over timing. Eli Lilly's solid pipeline and financial health suggest resilience, while its dividend yield and leadership in weight-loss therapies highlight investment appeal. The market reaction may have been excessive given the company's long-term prospects.
AppLovin stock heads into Monday under a short-seller shadow as Fed week nears
Previous Story

AppLovin stock heads into Monday under a short-seller shadow as Fed week nears

Blackstone stock slides into a make-or-break week: what BX investors are watching
Next Story

Blackstone stock slides into a make-or-break week: what BX investors are watching

Go toTop